Biomerica, Inc. BMRA

BMRA Company Overview

Biomerica, Inc. is a U.S.-based biomedical technology and diagnostics company that develops, manufactures, and markets medical diagnostic products used for the detection and monitoring of chronic diseases and medical conditions. The company primarily operates within the in-vitro diagnostics (IVD) and healthcare diagnostics industries, with a focus on gastrointestinal diseases, food intolerance testing, diabetes monitoring, and infectious disease diagnostics. Its products are sold to hospitals, laboratories, physicians’ offices, clinics, and distributors in domestic and international markets.

The company’s primary revenue drivers include diagnostic test kits, point-of-care testing technologies, and laboratory-based assays. One of Biomerica’s most prominent development platforms is its gastrointestinal diagnostic portfolio, including products associated with celiac disease and irritable bowel syndrome (IBS). The company has also pursued commercialization opportunities around its InFoods® technology platform, designed to identify patient-specific foods associated with IBS symptoms. Founded in 1971 and headquartered in Irvine, California, Biomerica evolved from a diagnostic reagent manufacturer into a specialized developer of patented diagnostic technologies targeting underserved clinical markets.